Switzerland· 62799002
Montelukast Spirig HC 4, Kautabletten
A montelukast product containing montelukastum, registered in Switzerland by Spirig HealthCare AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Montelukast is registered in 19 of 19 countries.
Countries holding a registration under ATC R03DC03 (montelukast), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 11 of them publish a price we can compare per daily dose
Montelukast · ATC R03DC03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of montelukast costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in Italy to $1.71 in Spain — a ×2.9 gap.
- Switzerland: $1.41 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Montelukast · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- ES Spain$1.71
- CH Switzerland$1.41
- FR France$0.71
- IT Italy$0.59
The record
At a glance
Swissmedic (Switzerland)- Active substance
- montelukastum
- Manufacturer
- Spirig HealthCare AG
- Country
- Switzerland (CH)
- ATC code
- R03DC03
- ATC class
- Montelukast
- Defined daily dose
- 10 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768062799002698 StkCHF 69
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
565 interactions on record for montelukast.
Graded by severity as the source publishes them — 101 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Montelukast · interactions on record
565 records
- 101 moderate
- 464 info
Most severe, free to view
- MiconazoleA07AC01moderate
- TroglitazoneA10BG01moderate
- NateglinideA10BX03moderate
- NitisinoneA16AX04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Montelukast in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCASTISPIRSandoz s.r.o., Praha
- FinlandAirathonN.V. Organon
- United KingdomMontelukast 4mg chewable tablets sugar freeMilpharm Ltd
- United Statesmontelukast sodiumUnichem Pharmaceuticals (USA), Inc.
- SpainMONKASTA 4 mg COMPRIMIDOS MASTICABLES EFGKrka D.D. Novo Mesto
- PolandAstmodilPolfarmex S.A.
- BelgiumMontelukast AB 4 mgAurobindo Pharma
- ItalyALEASTLANOVA FARMACEUTICI S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Lanair, Montelukast +pharma
- Belgium · Montelukast Ab, Montelukast Eg
- Bulgaria · Eфира, Moнтелукаст Акорд
- Cyprus · Modulair, Montelukast Krka
- Czechia · Castispir, Monkasta
- Germany · Monkasta, Montelair Hexal
- Denmark · Montelukast "sandoz", Montelukast Accord Healthcare
- Estonia · Monkasta, Montelukast Teva
- Spain · Monkasta, Montelukast Accord
- Finland · Montelukast, Montelukast Accord
- France · Montelukast Accord, Montelukast Accord Healthcare
- United Kingdom (Northern Ireland) · Montelukast, Montelukast for Children From 6 To 14 Years Accord Healthcare
- Greece · Apilone, Ascolin
- Croatia · Melarth, Monkasta
- Hungary · Eonic, Monalux
- Ireland · Montelair, Montelukast
- Iceland · Montelukast Alvogen, Singulair
- Italy · Aleast Per Bambini Da 2 A 5 Anni, Aleast Per Bambini Da 6 A 14 Anni
- Lithuania · Monkasta
- Luxembourg · Montelukast Eurogenerics, Montelukast Ratiopharm
- Latvia · Monkasta
- Malta · Actamone, Monkasta
- Netherlands · Montelukast Accord, Montelukast Amarox
- Norway · Montelukast Krka, Montelukast Sandoz
- Poland · Asmenol, Astmodil
- Portugal · Montelucaste Accord, Montelucaste Alter
- Romania · Monkasta, Montelukast Arena
- Sweden · Montelukast Accord, Montelukast Amarox
- Slovenia · Monkasta, Singulair
- Slovakia · Astmasan, Belokast
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc2f4076-04ca-4d92-a885-2d260206d9e2 GET /v1/drugs/dc2f4076-04ca-4d92-a885-2d260206d9e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "montelukastum 4 mg",
"valid_from": "2013-10-01",
"limitations": "[{\"description\":\"Anwendung von Montelukast zur Linderung von Symptomen der allergischen Rhinitis (saisonale und perenniale allergische Rhinitis bei Erwachsenen und Kindern ab 2 Jahren) nur wenn andere Therapien (intranasale Kortikosteroide und orale Antihistaminika der 2./3. Generation) nicht wirksam sind oder kontraindiziert sind oder aus anderen medizinischen Gründen nicht angezeigt sind, oder wenn die Behandlung mit anderen Therapien nicht ausreichend angesprochen hat.<br>\\n<br>\\nAnwendung von Montelukast zur Behandlung von chronischem Bronchialasthma nur wenn andere Therapien (Standardcontrollerbehandlung mit ICS/LABA) nicht wirksam sind oder kontraindiziert sind oder aus anderen medizinischen Gründen nicht angezeigt sind oder wenn die Behandlung mit anderen Therapien nicht ausreichend angesprochen hat, oder für bereits auf Montelukast eingestellte Patienten<br>\\n <br>\\n · bei Erwachsenen und Kindern ab 6 Jahren mit gesicherter Asthmadiagnose. <br>\\n<br>\\n · bei Kindern von 2 bis 5 Jahren mit gesicherter Asthmadiagnose:<br>\\n<br>\\na) als Monotherapie bei leichten, nicht steroidpflichtigen Formen<br>\\n<br>\\nb) als Zusatztherapie zu Kortikoiden bei schwereren Formen<br>\\n<br>\\n · bei Kindern von 6 Monaten bis 2 Jahren mit gesicherter Asthmadiagnose:<br>\\n<br>\\na) als Monotherapie bei leichten, nicht steroidpflichtigen Formen, vor allem wenn eine Inhalationstherapie schwierig durchführbar ist<br>\\n<br>\\nb) als Zusatztherapie zu Kortikoiden bei schwereren Formen<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2026-04-01\"}]",
"galenic_form": "Kautabl 4 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2013-10-01",
"self_retention_pct": 10
}See everything about montelukast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.